Clinical trial
Introduction of EndoSign ® in Management of Barrett's Oesophagus - a Swedish Feasibility Study
NCT07036432 is registered in ClinicalTrials.gov with Vastra Gotaland Region as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Introduction of EndoSign ® in Management of Barrett's Oesophagus - a Swedish Feasibility Study
- Lead sponsor
- Vastra Gotaland Region
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 1, 2023
- Completion date
- March 1, 2025
- Enrollment
- 70 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.